Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targets-Reference-Cited by-同舟云学术

Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targets

Published:2011-10-03 Issue:18 Volume:31 Page:2258-2269
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Berardi S,Caivano A,Ria R,Nico B,Savino R,Terracciano R,De Tullio G,Ferrucci A,De Luisi A,Moschetta M,Mangialardi G,Catacchio I,Basile A,Guarini A,Zito A,Ditonno P,Musto P,Dammacco F,Ribatti D,Vacca A

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc2011412.pdf

Reference49 articles.

1. Aird WC . (2007). Phenotypic heterogeneity of the endothelium. Circ Res 100: 174–190.

2. Aitken A . (2006). 14-3-3 proteins: a historic overview. Semin Cancer Biol 16: 162–172.

3. Andley UP . (2007). Crystallins in the eye: Function and pathology. Prog Retin Eye Res 26: 78–98.

4. Arrigo AP, Simon S, Gibert B, Kretz-Remy C, Nivon M, Czekalla A et al. (2007). Hsp27 (HspB1) and aB-crystallin (HspB5) as therapeutic targets. FEBS Lett 581: 3665–3674.

5. Bedolla RG, Wang Y, Asuncion A, Chamie K, Siddiqui S, Mudryj MM et al. (2009). Nuclear versus cytoplasmic localization of filamin A in prostate cancer: immunohistochemical correlation with metastases. Clin Cancer Res 15: 788–796.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alpha-B-Crystallin overexpression is sufficient to promote tumorigenesis and metastasis in mice;Experimental Hematology & Oncology;2023-01-09

2. Pathways of Angiogenic and Inflammatory Cytokines in Multiple Myeloma: Role in Plasma Cell Clonal Expansion and Drug Resistance;Journal of Clinical Medicine;2022-11-01

3. Alpha-B-Crystallin overexpression is sufficient to promote tumorigenesis and metastasis in mice;2022-07-29

4. Natural Killer Cells in the Malignant Niche of Multiple Myeloma;Frontiers in Immunology;2022-01-11

5. Identification of new therapeutic targets of bone cancers by proteomic strategies;Bone Cancer;2022